EMERGENT BIODEFENSE OPERATIONS LANSING LLC
...UEIJLLWGQX6LNA5·Profile updated 2026-05-13
About this recipient
EMERGENT BIODEFENSE OPERATIONS LANSING LLC has received $211.4M in tracked federal funding across the ingest window.
The largest single source of funding is Department of Health and Human Services, which dominates the recipient's federal portfolio. We surface the full breakdown of contracts and grants below.
A longer, LLM-generated profile becomes available for the top entities by total $ awarded. We do not take editorial direction from recipients.
Portfolio by sector
Sectors classified by LLM on each award.
- biotech1 award$211.4M 100%
Portfolio status
Based on each award's period of performance.
Active
1
active100% of awards
Expiring (≤90d)
0
expiring · 30d0% of awards
Expired
0
expired0% of awards
No POP
0
—0% of awards
Top awarding agencies
Department of Health and Human Services
$211.4M 100%
Based on 1 awards totaling $211,409,788.
Awards
Top 1 by amount
| Action date | Recipient | Agency | Amount | Description | Sector | Status |
|---|---|---|---|---|---|---|
| — | EMERGENT BIODEFENSE OPERATIONS LANSING LLC | Department of Health and Human Services | $211,409,788 | CHIMERIX INC: AR&D FOR SMALLPOX ANTIVIRAL | biotech | active |
Sources
USAspending.gov — all awards for this UEI →SAM.gov entity registration →
Profile compiled from publicly available USAspending.gov records, ingested and entity-resolved by The Buildout's pipeline.